News | Health & Safety
21 Aug 2017 5:12
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Ski Report
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     19 Aug: All Blacks great Meads 'extremely unwell'
     19 Aug: Protesters greet PM English in Dunedin
     19 Aug: Vaccine advice in pregnancy matters: study
     18 Aug: Yemen war: Human rights groups urge UN to put Saudi Arabia on blacklist of shame over child deaths
     18 Aug: No cochlear implant due to funding
     16 Aug: Help me hear again PM, Danielle pleads
     16 Aug: Pain drugs may breach Fair Trading Act
     Top Stories

    RUGBY RUGBY
    Colin Meads, New Zealand rugby union legend, dies aged 81 More...


    BUSINESS BUSINESS
    NZ should renegotiate TPP now: Robertson More...



     Today's News

    International:
    North Korea receiving constant oil supply as China refuses to go all in on isolating rogue state 4:37

    Living & Travel:
    Golden retriever unearths $100,000 worth of heroin while digging in backyard 4:37

    Tennis:
    Nick Kyrgios beats David Ferrer to reach Cincinnati Masters final, fresh after Rafael Nadal scalp 4:37

    Law and Order:
    Barcelona terrorist attack: What we know 4:37

    Auckland:
    Slip undermines Auckland home 21:57

    Motoring:
    Man dies in hospital days after crash 21:17

    Accident and Emergency:
    Fatal crash on Napier to Taupo road 20:37

    Law and Order:
    Tongariro search to continue 20:37

    Rugby League:
    Rooster JWH escapes NRL ban for elbow 18:57

    Rugby League:
    Hoffman no certainty for Melbourne goodbye 18:37


     News Search






    Power Search


    © 2017 New Zealand City Ltd